Investor Relations

Investor Relations

Vital Therapies, Inc. is a biotherapeutic company developing a cell-based system for the treatment of acute forms of liver failure. The company’s lead product candidate, the ELAD® System, is a human cell-based, bio-artificial liver support system currently in Phase III clinical trials.  Vital Therapies, Inc. is based in San Diego, California.